Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study

NCT: NCT06172699 · COMPLETED

NCT IDNCT06172699
StatusCOMPLETED
Start Date2024-01-01
Completion2025-11-10
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, non-randomized, multi-center, real-world post-market study to collect and evaluate data regarding the performance of the enhanced atrial fibrillation detection algorithm of the Assert-IQTM Implantable Cardiac Monitor (ICM) device.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑